Safety and Tolerability of Once-Daily OROS® Hydromorphone Extended-Release in Opioid-Tolerant Adults With Moderate-to-Severe Chronic Cancer and Noncancer Pain: Pooled Analysis of 11 Clinical Studies

  • Srinivas R. Nalamachu, Michael Kutch, Martin E. Hale
  • Journal of Pain and Symptom Management, December 2012, Elsevier
  • DOI: 10.1016/j.jpainsymman.2011.12.280

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Mr Michael Kutch